Table 4.
Risk Analysis by Treatment and Age of Hereditary Retinoblastoma Diagnosis in Patients with Uterine Leiomyosarcoma
| No. female subjects | Obs | Exp | SIR | 95% CI | EAR/10E4 | |
|---|---|---|---|---|---|---|
| Any Radiation | ||||||
| Yes | 459 | 4 | 0.01 | 298 | 81–756 | 3.65 |
| No | 63 | 1 | 0 | 215 | 5.4–1196 | 5.22 |
| Any Chemo | ||||||
| Yes | 200 | 3 | 0 | 433 | 52–1562 | 4.06 |
| No | 317 | 2 | 0.01 | 229 | 47–670 | 3.87 |
| Age at Rb Dx | ||||||
| 0–12 mos | 301 | 2 | 0.01 | 291 | 35–1050 | 2.79 |
| >12 mos | 224 | 3 | 0.01 | 269 | 55–786 | 5.21 |
Obs, observed; Exp, expected; SIR, standardized incidence ratio; 95% CI, 95% confidence interval; EAR, excess absolute risk.